News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Millar Kerri-Ann
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2022 |
4
| Millar Kerri-Ann (CFO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 85,000 options to buy
@ $6.91, valued at
$587.4k
Granted 10,000 options to buy
@ $5.01, valued at
$50.1k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2020 |
4
| Millar Kerri-Ann (CFO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 1,900 shares
@ $0
Granted 65,000 options to buy
@ $19.87, valued at
$1.3M
Granted 20,000 restricted stock units
@ $0
Exercised 6,666 restricted stock units
@ $0 |
|
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2019 |
4
| Millar Kerri-Ann (VP-Finance) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.42, valued at
$192.6k
|
|
| 08/29/2018 |
4
| Millar Kerri-Ann (VP-Finance) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Bought 1,000 shares
@ $8.48, valued at
$8.5k
|
|
| 07/25/2018 |
4
| Millar Kerri-Ann (VP-Finance) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $11.54, valued at
$577k
|
|
|
|